Markku Lähteenvuo

Vascular Endothelial Growth Factor-B Induces Myocardium-Specific Angiogenesis and Arteriogenesis via Vascular Endothelial Growth Factor Receptor-1– and Neuropilin Receptor-1–Dependent Mechanisms

Johanna Lähteenvuo, Markku Lähteenvuo, Antti Kivelä et al. · Circulation · 2009 · 195 citations

Medicine, Cardiology, Pharmacology +14

Growth Factor Therapy and Autologous Lymph Node Transfer in Lymphedema

Markku Lähteenvuo, Krista Honkonen, Tomi V. Tervala et al. · Circulation · 2011 · 181 citations

Medicine, Plastic Surgery, Surgery +17

Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder

Markku Lähteenvuo, Antti Tanskanen, Heidi Taipale et al. · JAMA Psychiatry · 2018 · 147 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +13

Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland

Heidi Taipale, Marco Solmi, Markku Lähteenvuo et al. · The Lancet Psychiatry · 2021 · 138 citations

Medicine, Oncology, Psychiatry +12

Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptors

Petri I. Mäkinen, Jari P. Lappalainen, Suvi E. Heinonen et al. · Cardiovascular Research · 2010 · 119 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13